GlassScriptPhysician profile
Jeffrey Scott Osborn
NPI 1043288368
$69,438.77
in general payments reported to CMS, 2019-2025
9 companies · $3,319 in 2025
The $3,319 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $5,600 · 2021: $21K · 2022: $4,061 · 2023: $4,063 · 2024: $3,854 · 2025: $3,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,432 · Food and Beverage: $3,204 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,431.86 |
| Food and Beverage | $3,203.72 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $41,972.04 | 2019-2025 | Merlin@Home, Aveir, Assurity |
| Merit Medical Systems INC | $11,016.25 | 2019-2025 | |
| Medtronic, INC. | $6,412.78 | 2021-2024 | Evera Mri Xt Dr Surescan, Micra, Azure Xt Dr Mri Surescan |
| Philips North America LLC | $5,848.92 | 2019-2022 | |
| Boston Scientific Corporation | $2,604.24 | 2019-2025 | General - Therapies, Endotak Reliance S |
| Medtronic Vascular, INC. | $1,461.88 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $76.67 | 2019-2023 | Optimizer |
| Baxter Healthcare | $26.01 | 2023 | |
| Biotronik INC. | $19.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Osborn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.